No abstract available
MeSH terms
-
Chelation Therapy*
-
Deferiprone
-
Deferoxamine / adverse effects
-
Deferoxamine / pharmacokinetics
-
Deferoxamine / therapeutic use*
-
Erythropoiesis
-
Hemosiderosis / drug therapy*
-
Hemosiderosis / etiology
-
Humans
-
Iron
-
Iron Chelating Agents / therapeutic use*
-
Pentetic Acid / therapeutic use
-
Pyridones / therapeutic use
-
Thalassemia / complications*
-
Thalassemia / metabolism
Substances
-
Iron Chelating Agents
-
Pyridones
-
Deferiprone
-
Pentetic Acid
-
Iron
-
Deferoxamine